Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Considerations in pharmaceutical conversion: focus on antihistamines.

S B Garbus1, B W Moulton, E O Meltzer

  • 1HLS Corp, Little Falls, NJ 07424, USA.

The American Journal of Managed Care
|March 8, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meta-analyses of the efficacy of pharmacotherapies and sublingual allergy immunotherapy tablets for allergic rhinitis in adults and children.

Rhinology·2021
Same author

Accessory spleen embolization: An option for refractory idiopathic thrombocytopenic purpura (ITP).

Diagnostic and interventional imaging·2019
Same author

Research abstracts presented at the Eastern Allergy Conference, Palm Beach, Florida, May 6-9, 2010.

Allergy and asthma proceedings·2017
Same author

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2017
Same author

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Clinical and translational allergy·2017
Same author

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2016

Pharmaceutical conversion, including generic, brand, and therapeutic substitution, is rising in managed care. Decisions must prioritize patient-centered care, considering clinical, psychosocial, safety, adherence, satisfaction, and legal factors beyond just drug cost.

Area of Science:

  • Pharmacoeconomics
  • Health Services Research
  • Clinical Pharmacy

Background:

  • Pharmaceutical conversion, involving generic, brand, and therapeutic substitution, is increasingly prevalent in managed care.
  • This practice impacts managed care organizations, healthcare providers, and patients.
  • While drug cost is a factor, other considerations are crucial.

Purpose of the Study:

  • To discuss the multifaceted implications of pharmaceutical conversion.
  • To highlight key decision-making factors beyond cost.
  • To use antihistamines as a case study for pharmaceutical conversion.

Main Methods:

  • Literature review and analysis of pharmaceutical conversion practices.
  • Examination of clinical, psychosocial, safety, adherence, satisfaction, and legal issues.

Related Experiment Videos

  • Case study approach using the antihistamine drug class.

    • Main Results:

    • Drug cost is not the sole determinant in pharmaceutical conversion decisions.
    • Clinical, psychosocial, safety, patient adherence, satisfaction, and legal aspects are critical.
    • Patient-centered care must guide all conversion decisions.

    Conclusions:

    • Pharmaceutical conversion requires a holistic approach, balancing cost with patient well-being.
    • Managed care strategies for conversion must integrate diverse patient-specific factors.
    • Antihistamine conversion exemplifies the complexities and considerations involved.